Despite its significance, research on evf‐2 remains relatively limited, primarily focusing on its involvement in neurological disorders and tumorigenesis.[19] Notably, the potential contribution of evf‐2 to the pathogenesis and progression of kidney diseases, particularly DN, remains largely unexplored. Here, DLX6-AS1 is linked to nervous system disorder.